TENX

1.25010.07%
TR

Thomas R. Staab

Chief Financial Officer

Mr. Thomas R. Staab, II, also known as Tom, CPA, serves as Chief Financial Officer at Tenax Therapeutics, Inc. since May 11, 2026. He is Chief Financial Officer and Secretary at LENSAR, Inc. since May 2020. Mr. Staab served as the Chief Financial Officer, Senior Vice President and Treasurer of BioCryst Pharmaceuticals, Inc. since July 1, 2011 until February 29, 2020 and its Principal Accounting Officer since January 25, 2013 February 29, 2020. Mr. Staab has nearly several years of finance and biotech accomplishments to BioCryst. His experience includes equity financing, strategic alliances, mergers and acquisitions, drug commercialization, SEC reporting, treasury management and Investor Relations. He served as Chief Financial Officer and Treasurer of Inspire Pharmaceuticals, Inc. since May 2003, Executive Vice President since September 1, 2008 and served as its Principal Accounting Officer. He served as Vice President of Inspire Pharmaceuticals, Inc., since May 2003. He joined Inspire Pharmaceuticals Inc., in May 2003. Previously, Mr. Staab held senior financial positions with Triangle Pharmaceuticals Inc. He served for few years at Triangle as its Vice President and Treasurer from August 2000 to May 2003 and its Acting Chief Financial Officer from July 2002 to May 2003. Prior to Triangle, he served at Price Waterhouse LLP for few years, w here he worked with publicly and privately held companies focusing on audits, business advisory and tax services. He serves on the Board of the North Carolina Biosciences Organization. He also serves on the Board of the Triangle Community Foundation. He is a Certified Public Accountant. Mr. Staab received his BS in Business Administration and Master of Accounting degrees from The University of North Carolina, Chapel Hill.

Positions